"They will need to get the product to market and register sales"
This is the headline in RED on slide 9 from the investor presentation. I would say the terms of agreement have been reached and will be signed as soon as 510k approved.
We anticipate commercial sales in US Market Early
2016 once 510(k) approved
From slide 15
"In discussion with multinational device companies"
Ann: PolyNovo Awarded BARDA Contract for Burns Trial, page-46
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
-0.020(0.82%) |
Mkt cap ! $1.685B | |||
| Open | High | Low | Value | Volume |
| $2.43 | $2.43 | $2.40 | $256.2K | 105.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 8269 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 37666 | 22 |
View Market Depth
| Last trade - 10.59am 29/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |